Literature DB >> 31800211

Synthesis of a Clay-Based Nanoagent for Photonanomedicine.

Huan Wu1,2, Weifan Wang3, Zhilun Zhang1, Jinfeng Li1, Jiayan Zhao1, Yiyun Liu1, Chenyao Wu1, Mingxian Huang1, Yongsheng Li2, Shige Wang1.   

Abstract

Photo-induced cancer therapies, mainly including photothermal therapy (PTT) and photodynamic therapy (PDT), have attracted numerous attentions owing to the high selectivity, convenience, and few side effects. However, single PTT usually requires high laser power density, and single PDT usually needs a high photosensitizer dosage. Herein, a kind of composite nanocarrier based on clay (laponite)-polypyrrole (LP) nanodisks was synthesized via the in situ polymerization of pyrrole in the interlayer space of laponite. LP composite nanodisks were then coated with polyvinylpyrrolidone (PVP) to form the LP-PVP (LPP) composite nanodisks which show an excellent colloidal stability and in vitro and in vivo biocompatibility. The interlayer space of LPP can be further used for the loading of Chlorin e6 (Ce6), with an ultrahigh loading capacity of about 89.2%. Furthermore, the LPP nanocarrier can enhance the PDT effect of Ce6 under the irradiation of a 660 nm laser, through enhancing its solubility and cellular uptake amount. Besides, it was found that LPP nanodisks exhibit a more outstanding photothermal performance under a 980 nm near-infrared laser (NIR) than a 808 nm NIR laser, with the photothermal conversion efficiency of 45.7 and 27.7%, respectively. The in vitro and in vivo tumor therapy results evidently confirm that the Ce6-loaded LPP nanodisks have a combined tumor PTT and PDT effect, which can significantly suppress the tumor malignant proliferation.

Entities:  

Keywords:  Chlorin e6; laponite; photodynamic; photothermal; polypyrrole

Year:  2019        PMID: 31800211     DOI: 10.1021/acsami.9b19930

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.

Authors:  Junjie Liu; Xiu Zhao; Weimin Nie; Yue Yang; Chengcheng Wu; Wei Liu; Kaixiang Zhang; Zhenzhong Zhang; Jinjin Shi
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

2.  131I-Labeled Multifunctional Polyethylenimine/Doxorubicin Complexes with pH-Controlled Cellular Uptake Property for Enhanced SPECT Imaging and Chemo/Radiotherapy of Tumors.

Authors:  Jingyi Zhu; Junxing Yang; Lingzhou Zhao; Pingping Zhao; Jiqin Yang; Jinhua Zhao; Wenjun Miao
Journal:  Int J Nanomedicine       Date:  2021-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.